MannKind Corp. (MNKD)
5.54
+0.01
(+0.18%)
USD |
NASDAQ |
Feb 20, 16:00
5.545
0.00 (0.00%)
After-Hours: 20:00
MannKind SG&A Expense (Quarterly) : 58.18M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 117.08M |
| Keros Therapeutics, Inc. | 10.13M |
| BioMarin Pharmaceutical, Inc. | 268.40M |
| Ionis Pharmaceuticals, Inc. | 96.81M |
| Vertex Pharmaceuticals, Inc. | 487.00M |